Corporate Overview
Asthmatx Inc. is a privately-held medical device company focused on helping patients breathe easier. Asthmatx has developed a catheter-based outpatient procedure that provides long lasting and improved asthma control for adult severe asthma patients.
Product Overview
Bronchial thermoplasty, delivered by the Alair® System, is a minimally invasive procedure that delivers precisely controlled thermal energy to the airway wall to reduce the amount of airway smooth muscle and lessen these muscles’ ability to narrow the airway, thereby reducing symptoms in patients with severe asthma.
Asthmatx, Inc. has taken a thoughtful, step-wise, scientific approach in its development of the Alair® Bronchial Thermoplasty System. To date, Asthmatx has conducted 4 clinical studies in patients with asthma at over 30 institutions around the world. Safety and effectiveness have been demonstrated over the long term with therapeutic benefits over and above standard medical care.
The Alair® Bronchial Thermoplasty System was approved by the FDA on April 27, 2010 for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists.
For more information, please visit www.BTforAsthma.com or www.bronchialthermoplasty.com
